Technical Analysis for ETNB - 89bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 9.20 | 1.21% | 0.11 |
ETNB closed up 1.21 percent on Wednesday, May 15, 2024, on 84 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Crossed Above 20 DMA | Bullish | 1.21% | |
| Bollinger Band Squeeze | Range Contraction | 1.21% | |
| Narrow Range Bar | Range Contraction | 1.21% |
| Alert | Time |
|---|---|
| Rose Above Upper Bollinger Band | about 20 hours ago |
| Up 5% | about 20 hours ago |
| Upper Bollinger Band Resistance | about 20 hours ago |
| Up 1 ATR | about 20 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Alcohol Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease Innovative Therapies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Alcohol Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease Innovative Therapies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.93 |
| 52 Week Low | 6.575 |
| Average Volume | 951,983 |
| 200-Day Moving Average | 11.36 |
| 50-Day Moving Average | 10.39 |
| 20-Day Moving Average | 8.90 |
| 10-Day Moving Average | 9.09 |
| Average True Range | 0.51 |
| RSI (14) | 47.64 |
| ADX | 16.54 |
| +DI | 28.48 |
| -DI | 24.63 |
| Chandelier Exit (Long, 3 ATRs) | 8.29 |
| Chandelier Exit (Short, 3 ATRs) | 9.58 |
| Upper Bollinger Bands | 9.61 |
| Lower Bollinger Band | 8.19 |
| Percent B (%b) | 0.71 |
| BandWidth | 15.93 |
| MACD Line | -0.29 |
| MACD Signal Line | -0.40 |
| MACD Histogram | 0.1112 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.94 | ||||
| Resistance 3 (R3) | 10.01 | 9.83 | 9.81 | ||
| Resistance 2 (R2) | 9.83 | 9.65 | 9.80 | 9.77 | |
| Resistance 1 (R1) | 9.52 | 9.53 | 9.68 | 9.45 | 9.73 |
| Pivot Point | 9.34 | 9.34 | 9.42 | 9.31 | 9.34 |
| Support 1 (S1) | 9.03 | 9.16 | 9.19 | 8.96 | 8.67 |
| Support 2 (S2) | 8.85 | 9.04 | 8.82 | 8.63 | |
| Support 3 (S3) | 8.54 | 8.85 | 8.59 | ||
| Support 4 (S4) | 8.47 |
